SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Total Debt
Short-term and long-term borrowings combined.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt of $1.61M in Q1 FY2026
Q1 FY2026 total debt was $1.61M.
Context
- Total debt amounted to 0.6% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 1.58M USD
- Year-over-year change
- —
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.58M | — |
Total Debt vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Total debt amounts to 0.6% of total assets for SGP, versus a peer median of 10.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $5.33B USD | +1.8% | +1.2% | 17.0% | |
| Jun 2026 | $5.12B USD | +3.1% | +28.1% | 36.9% | |
| Jun 2026 | $102.84M USD | -2.1% | -28.6% | 11.2% | |
| Mar 2026 | $79.46M USD | +4.2% | +7.5% | 10.8% | |
| Mar 2026 | $41.76M USD | +3.2% | +5.2% | 38.1% | |
| Apr 2026 | $37.29M USD | +1.7% | +7.3% | 8.3% | |
| Mar 2026 | $20.23M USD | -16.0% | -23.5% | 7.0% | |
| Mar 2026 | $10.83M USD | -10.1% | -37.4% | 3.6% | |
| Mar 2026 | CHF 2.24M CHF | +103.2% | -73.4% | 0.9% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $1.61M USD | — | — | 0.6% |
| Peer median (excluding SGP) | — | +1.8% | +1.2% | 10.8% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.